Irisin is studied in laboratory research as a peptide derived from the membrane protein FNDC5 and as a tool in myokine-signaling studies in vitro. Laboratory work uses defined synthetic material so experiments are reproducible from lot to lot.

Structure: irisin corresponds to the extracellular fibronectin type III domain fragment of FNDC5, and its glycosylation state and fragment boundaries are key variables in laboratory studies comparing irisin preparations in controlled systems. Identity and purity are confirmed by HPLC and mass spectrometry, and the lot-matched certificate of analysis is reviewed before use.

Laboratory applications: cell culture assays, structure-activity studies comparing irisin fragments and analogues, and stability studies under controlled laboratory conditions. Vehicle controls, analytical verification, and replication are standard. In vitro findings describe behavior in laboratory systems only; no conclusions about human use can be drawn from them.

Analytical notes: store lyophilized material sealed, protected from light and moisture; verify identity and purity by HPLC/MS on receipt; avoid repeated freeze-thaw cycles; record lot numbers in laboratory documentation.

Disclaimer: This material is supplied for laboratory research purposes only. Not for human consumption. Not for medical, therapeutic, diagnostic, or veterinary use. No dosing, reconstitution-for-use, or efficacy information is provided or implied.

Citations: standard irisin and FNDC5 literature; peptide characterization reviews; standard HPLC/MS methods.